SCHEMBL4186731

SCHEMBL4186731

O=C(O)Nc1ccccc1NC(=O)c1ccc2c(c1)CCC2=NO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.43
TERT O14746 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
SRD5A1 P18405 1/20 0.43
SRD5A2 P31213 1/20 0.43
KCNK2 O95069 1/20 0.42
PTGS2 P35354 1/20 0.42
MAPK14 Q16539 2/20 0.42
POLB P06746 2/20 0.41
HPGD P15428 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186723 1.00 TOP1 (0.43) TOP1TERTHTTMAPTRAB9A
SCHEMBL4188665 0.83 MAPK14 (0.54) TOP1TERTKMT2AMEN1SRD5A1
SCHEMBL13653103 0.83 TOP1 (0.41) TOP1TERTHTTMAPTRAB9A
SCHEMBL4187038 0.81 RAB9A (0.39) TOP1HTTMAPTRAB9ASMN1; SMN2
SCHEMBL28769912 0.78 RAB9A (0.43) TOP1HTTMAPTRAB9ASMN1; SMN2
SCHEMBL803513 0.72 HTT (0.51) HTTMAPTRAB9ASMN1; SMN2NPC1
SCHEMBL1274342 0.70 MAPT (0.38) HTTMAPTSMN1; SMN2MAPK14POLB
SCHEMBL4192759 0.70 MEN1 (0.46) TOP1TERTMAPTRAB9ANPC1
SCHEMBL2882845 0.70 KMT2A (0.59) TOP1TERTRAB9ANPC1KMT2A
SCHEMBL1705539 0.69 HDAC1 (0.61) MAPTRAB9ASMN1; SMN2NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247590-A1 Indane amides MKI67, PPIP5K2, CCNA1 TOP1 680/4885TERT 967/4885HTT 1496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.